RESUMO
BACKGROUND: Real-world evidence is limited regarding the relationship between race and use of durvalumab, an immunotherapy approved for use in adults with unresectable stage III non-small cell lung cancer (NSCLC) post-chemoradiotherapy (CRT). This study aimed to evaluate if durvalumab treatment patterns differed by race in patients with unresectable stage III NSCLC in a Veterans Health Administration (VHA) population. MATERIALS AND METHODS: This was a retrospective analysis of White and Black adults with unresectable stage III NSCLC treated with durvalumab presenting to any VHA facility in the US from January 1, 2017, to June 30, 2020. Data captured included baseline characteristics and durvalumab treatment patterns, including treatment initiation delay (TID), interruption (TI), and discontinuation (TD); defined as CRT completion to durvalumab initiation greater than 42 days, greater than 28 days between durvalumab infusions, and more than 28 days from the last durvalumab dose with no new durvalumab restarts, respectively. The number of doses, duration of therapy, and adverse events were also collected. RESULTS: A total of 924 patients were included in this study (White = 726; Black = 198). Race was not a significant factor in a multivariate logistic regression model for TID (OR, 1.39; 95% CI, 0.81-2.37), TI (OR, 1.58; 95% CI, 0.90-2.76), or TD (OR, 0.84; 95% CI, 0.50-1.38). There were also no significant differences in median (interquartile range [IQR]) number of doses (White: 15 [7-24], Black: 18 [7-25]; P = .25) or median (IQR) duration of therapy (White: 8.7 months [2.9-11.8], Black: 9.8 months [3.6-12.0]; P = .08), although Black patients were less likely to experience an immune-related adverse event (28% vs. 36%, P = .03) and less likely to experience pneumonitis (7% vs. 14%, P < .01). CONCLUSION: Race was not found to be linked with TID, TI, or TD in this real-world study of patients with unresectable stage III NSCLC treated with durvalumab at the VHA.
Assuntos
Carcinoma Pulmonar de Células não Pequenas , Equidade em Saúde , Neoplasias Pulmonares , Adulto , Humanos , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Estudos Retrospectivos , Saúde dos Veteranos , QuimiorradioterapiaRESUMO
O presente trabalho tem por objetivo problematizar as características do estágio supervisionado em Serviço Social, especialmente sob o prisma da supervisão direta de estágio em campo, abordagem ainda incipiente sob o ponto de vista de referências literárias, embora se constitua como dimensão formativa relevante e que demanda intensa e profunda reflexão. Desenvolveu-se estudo de nível descritivo (HERNANDEZ et al., 2013) e de natureza qualitativa (GOGOY, 1995), instrumentalizado por formulário survey (PINSONNEAULT; KRAEMER, 1993), por meio do qual buscou-se observar características dos assistentes sociais no processo de supervisão direta de estágio em campo. Conclui-se, pelo presente estudo, que qualificar o processo de supervisão de campo de estágio segue como relevante desafio a ser superado pela categoria profissional, dadas as condições por meio das quais o processo tem sido conduzido no cenário contemporâneo.
This paper aims to analyze the characteristics of supervised curricular traineeship in social work, especially about direct supervised training. There is a relative absence of literary references in this respect, a situation that demands intense investigation and deep reflection. A descriptive-level study (HERNANDEZ et al., 2013) and a qualitative nature (GOGOY, 1995) were carried out using a survey form (PINSONNEAULT; KRAEMER, 1993), which sought to observe characteristics of social workers in the process of direct supervision on field training. It's concluded, by the present study, that qualifying the process of field supervised training continues as a relevant challenge to be overcome by the professional category, given the conditions through which the process has developed in the contemporary scenario.
Assuntos
Serviço Social , Assistentes Sociais , Apoio ao Desenvolvimento de Recursos HumanosRESUMO
This study compared the ability of four measures of patient retention in HIV expert care to predict clinical outcomes. This retrospective study examined Veterans Health Administration (VHA) beneficiaries with HIV (ICD-9-CM codes 042 or V08) receiving expert care (defined as HIV-1 RNA viral load and CD4 cell count tests occurring within one week of each other) at VHA facilities from October 1, 2006, to September 30, 2008. Patients were ≥18 years old and continuous VHA users for at least 24 months after entry into expert care. Retention measures included: Annual Appointments (≥2 appointments annually at least 60 days apart), Missed Appointments (missed ≥25% of appointments), Infrequent Appointments (>6 months without an appointment), and Missed or Infrequent Appointments (missed ≥25% of appointments or >6 months without an appointment). Multivariable nominal logistic regression models were used to determine associations between retention measures and outcomes. Overall, 8,845 patients met study criteria. At baseline, 64% of patients were virologically suppressed and 37% had a CD4 cell count >500 cells/mm3. At 24 months, 82% were virologically suppressed and 46% had a CD4 cell count >500 cells/mm3. During follow-up, 13% progressed to AIDS, 48% visited the emergency department (ED), 28% were hospitalized, and 0.3% died. All four retention measures were associated with virologic suppression and antiretroviral therapy initiation at 24 months follow-up. Annual Appointments correlated positively with CD4 cell count >500 cells/mm3. Missed Appointments was predictive of all primary and secondary outcomes, including CD4 cell count ≤500 cells/mm3, progression to AIDS, ED visit, and hospitalization. Missed Appointments was the only measure to predict all primary and secondary outcomes. This finding could be useful to health care providers and public health organizations as they seek ways to optimize the health of HIV patients.